Company Valuation: Exosens

Data adjusted to current consolidation scope
Fiscal Period: December 2024 2025 2026 2027 2028
Market Cap 1 986.7 2,459 2,920 - -
Change - 149.26% 18.72% - -
Enterprise Value (EV) 1 1,131 2,657 3,074 3,008 2,924
Change - 134.98% 15.7% -2.15% -2.8%
P/E 31.9x 57.7x 34.7x 25.2x 21.2x
PBR 2.39x 5.51x 5.68x 4.83x 4.09x
PEG 0x 1.5x 0.4x 0.7x 1.1x
Capitalization / Revenue 2.5x 5.25x 5.17x 4.56x 4.05x
EV / Revenue 2.87x 5.68x 5.44x 4.7x 4.06x
EV / EBITDA 9.54x 17.5x 16.4x 14x 11.9x
EV / EBIT 11.9x 20.8x 20.2x 16.8x 14.2x
EV / FCF 20.4x 46.4x 48.4x 34.9x 25.9x
FCF Yield 4.9% 2.16% 2.07% 2.87% 3.85%
Dividend per Share 2 0.1 0.3 0.3822 0.5215 0.634
Rate of return 0.51% 0.62% 0.67% 0.91% 1.11%
EPS 2 0.61 0.84 1.652 2.275 2.707
Distribution rate 16.4% 35.7% 23.1% 22.9% 23.4%
Net sales 1 394.1 468.2 565.2 640 720.3
EBITDA 1 118.5 151.6 187.3 214.1 246
EBIT 1 95.3 127.6 152.4 179.5 205.6
Net income 1 30.7 42.7 81.74 114 134.9
Net Debt 1 144.1 197.7 154.6 88.38 4.297
Reference price 2 19.43 48.45 57.35 57.35 57.35
Nbr of stocks (in thousands) 50,783 50,762 50,911 - -
Announcement Date 03/03/25 23/02/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
34.57x5.42x16.35x0.67% 325.68Cr
33.68x6.16x25.33x0.62% 30TCr
30.72x2.97x17.17x1.47% 26TCr
26.25x1.75x12.96x1.74% 17TCr
-509.48x1.76x40.22x-.--% 15TCr
29.4x4.28x17.87x1.16% 14TCr
30.26x3.31x14.98x1.37% 14TCr
19.32x1.81x13.02x2.38% 14TCr
20.64x1.75x14.3x1.81% 9.48TCr
35.08x7.96x24.69x0.27% 7.71TCr
Average -24.96x 3.72x 19.69x 1.15% 14.78TCr
Weighted average by Cap. -25.02x 3.60x 20.35x 1.18%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Exosens

Historical PBR trend

Valuation ratios - PBR - Exosens

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Exosens

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Exosens


Year-on-year evolution of the Yield

Valuation ratios - Yield - Exosens